Id	Study	Session	StudySession	SL	TL	Task	Text	Part	SGroup	TGroup	STid	SGid	STseg	TokS	LenS	TTid	TGid	TTseg	TokT	LenT	Ins	Del	Munit	InEff	FixS	TrtS	OrtS	OrtT	MU1rtS	MU1rtT	FFTimeS	FFDurS	FixT	TrtT	FFTimeT	FFDurT	CrossS	CrossT	Pause	Dur	End	Edit	Pause1	Time1	Ins1	Del1	Dur1	End1	Edit1	Pause2	Time2	Ins2	Del2	Dur2	End2	Edit2	PauseR	TimeR	InsR	DelR	DurR	EditR	Edit
1	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	ICMRA	de_la_ICMRA	1	1	1	1	5	5	5+6+7	1	3	3	6	2	1	1.8000	0	0	0	0	0	0	0	0	0	0	0	0	7	1	817162	124090	1158418	[l]_la	0	0	0	0	0	0	---	0	0	0	0	0	0	---	817162	1034328	3	1	1472	l]_la[	[l]_la
2	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	high	alto	2	2	1	1	4	3	3	1	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-4	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
3	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	-	de	3	3	1	1	1	2	2	1	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
4	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	level	nivel	4	4	1	1	5	4	4	1	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
5	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	meeting	Reunión	5	5	1	1	7	1	1	1	1	7	8	2	3	1.5714	0	0	0	0	0	0	0	0	0	0	0	0	-3	1	137460	79648	1743960	"Reunión_de_alto_nivel_del_ICMRA_sobre_emergencias_sanitarias_mundiales_y_enfoques_regulatorios[""The_pandemic_has_increased_the_urgency_for_us_to_converge_on_responses_both_to_existing_regulatory_challenges_and_complex_new_ones,""_said_Emer_Cooke,_Chair_of_ICMRA_and_EMA’s_Executive_Director.☺[☺[_"	136539	136539	1	0	0	136539	Reunión_de_alto_nivel_del_ICMRA_sobre_emergencias_sanitarias_mundiales_y_enfoques_regulatorios	0	0	0	0	0	0	---	920	1692629	1	1	0	_[	"Reunión_de_alto_nivel_del_ICMRA_sobre_emergencias_sanitarias_mundiales_y_enfoques_regulatorios[""The_pandemic_has_increased_the_urgency_for_us_to_converge_on_responses_both_to_existing_regulatory_challenges_and_complex_new_ones,""_said_Emer_Cooke,_Chair_of_ICMRA_and_EMA’s_Executive_Director.☺[☺[_"
6	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	on	sobre	6	6	1	1	2	8	8	1	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	7	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
7	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	global	mundiales	7	7	1	1	6	11	11	1	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
8	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	health	sanitarias	8	8	1	1	6	10	10	1	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
9	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	emergencies	emergencias	9	9	1	1	11	9	9	1	1	11	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
10	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	and	y	10	10	1	1	3	12	12	1	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
11	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	regulatory	regulatorios	11	11	1	1	10	14	14	1	1	10	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
12	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	approaches	enfoques	12	12	1	1	10	13	13	1	1	10	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
13	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	On	Los_días	13	13	2	1	2	15	15+16	2	2	1	2	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	10382	20298	167219	Los_días_1_y_2_de_diciembre,_la_Coalición_Internacional_de_Autoridades_Reguladoras_de_Medicamentos_(ICMRA),_un_grupo_de_autoridades_reguladoras_de_medicamentos_y_expertos_de_todo_el_mundo,_celebró_una_reunión_de_alto_nivel_para_debatir_los_retos_regulatorios,_entre_ellos_los_que_se_plantean_durante_la_actual_pandemia_de_COVID-19.	10382	146921	1	0	0	146921	Los_días_1_y_2_de_diciembre,_la_Coalición_Internacional_de_Autoridades_Reguladoras_de_Medicamentos_(ICMRA),_un_grupo_de_autoridades_reguladoras_de_medicamentos_y_expertos_de_todo_el_mundo,_celebró_una_reunión_de_alto_nivel_para_debatir_los_retos_regulatorios,_entre_ellos_los_que_se_plantean_durante_la_actual_pandemia_de_COVID-19.	0	0	0	0	0	0	---	0	0	0	0	0	---	Los_días_1_y_2_de_diciembre,_la_Coalición_Internacional_de_Autoridades_Reguladoras_de_Medicamentos_(ICMRA),_un_grupo_de_autoridades_reguladoras_de_medicamentos_y_expertos_de_todo_el_mundo,_celebró_una_reunión_de_alto_nivel_para_debatir_los_retos_regulatorios,_entre_ellos_los_que_se_plantean_durante_la_actual_pandemia_de_COVID-19.
14	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	1	1	14	14	2	1	1	17	17	2	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
15	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	and	y	15	15	2	1	3	18	18	2	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
16	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	2	2	16	16	2	1	1	19	19	2	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
17	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	December	de_diciembre	17	17	2	1	8	20	20+21	2	2	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
18	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	,	,	18	18	2	1	1	22	22	2	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
19	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	International	Internacional	19	19	2	1	13	25	25	2	1	13	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
20	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	Coalition	la_Coalición	20	20	2	1	9	23	23+24	2	2	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
21	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	of	de	21	21	2	1	2	26	26	2	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
22	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	Medicines	de_Medicamentos	22	22	2	1	9	29	29+30	2	2	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	4	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
23	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	Regulatory	Reguladoras	23	23	2	1	10	28	28	2	1	10	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
24	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	Authorities	Autoridades	24	24	2	1	11	27	27	2	1	11	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
25	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	(	(	25	25	2	1	1	31	31	2	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	4	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
26	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	ICMRA	ICMRA	26	26	2	1	5	32	32	2	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
27	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	)	)	27	27	2	1	1	33	33	2	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
28	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	,	,	28	28	2	1	1	34	34	2	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
29	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	a	un	29	29	2	1	1	35	35	2	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
30	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	group	grupo	30	30	2	1	5	36	36	2	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
31	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	of	de	31	31	2	1	2	37	37	2	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
32	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	medicines	de_medicamentos	33	33	2	1	9	40	40+41	2	2	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	4	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
33	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	regulatory	reguladoras	34	34	2	1	10	39	39	2	1	10	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
34	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	authorities	autoridades	35	35	2	1	11	38	38	2	1	11	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
35	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	and	y	36	36	2	1	3	42	42	2	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	4	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
36	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	experts	expertos	37	37	2	1	7	43	43	2	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
37	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	from	de	38	38	2	1	4	44	44	2	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
38	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	around	todo	39	39	2	1	6	45	45	2	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
39	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	the	el	40	40	2	1	3	46	46	2	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
40	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	world	mundo	41	41	2	1	5	47	47	2	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
41	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	,	,	42	42	2	1	1	48	48	2	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
42	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	held	celebró	43	43	2	1	4	49	49	2	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
43	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	a	una	44	44	2	1	1	50	50	2	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
44	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	high	alto	45	45	2	1	4	53	53	2	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
45	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	-	de	46	46	2	1	1	52	52	2	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
46	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	level	nivel	47	47	2	1	5	54	54	2	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
47	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	meeting	reunión	48	48	2	1	7	51	51	2	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
48	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	to	para	49	49	2	1	2	55	55	2	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	4	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
49	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	discuss	debatir	50	50	2	1	7	56	56	2	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
50	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	regulatory	regulatorios	51	51	2	1	10	59	59	2	1	10	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
51	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	challenges	los_retos	52	52	2	1	10	57	57+58	2	2	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
52	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	,	,	53	53	2	1	1	60	60	2	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
53	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	including	entre_ellos	54	54	2	1	9	61	61+62	2	2	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
54	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	those	los	55	55	2	1	5	63	63	2	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
55	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	faced	planteados	56	56	2	1	5	64	64	2	1	5	22	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1468	244775	1487314	[_planteados	0	0	0	0	0	0	---	0	0	0	0	0	0	---	1468	1242539	11	0	2599	_planteados[	[_planteados
56	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	during	durante	57	57	2	1	6	65	65	2	1	6	10	42	1	-1.7097	0	0	0	0	0	0	0	0	0	0	0	0	1	1	122618	84121	1242539	[na]e[e]aron[noraetnalp_es_euq_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	122618	1158418	5	21	82653	na]e[e]aron[noraetnalp_es_euq_]	[na]e[e]aron[noraetnalp_es_euq_
57	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	the	la	58	58	2	1	3	66	66	2	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
58	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	ongoing	actual	59	59	2	1	7	67	67	2	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
59	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	COVID_-_19	de_COVID_-_19	60	60+61+62	2	3	8	69	69+70+71+72	2	4	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	5	3	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
60	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	pandemic	pandemia	63	63	2	1	8	68	68	2	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-4	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
61	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	.	.	64	64	2	1	1	73	73	2	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	5	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
62	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	Meeting	---	32	217	2	1	7	0	0	0	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	153	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
63	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	Participants	los_participantes	65	65	3	1	12	77	77+78	3	2	11	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	4	-152	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
64	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	from	de	66	66	3	1	4	79	79	3	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
65	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	the	los_los	67	67	3	1	3	80	80+84	3	2	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	5	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
66	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	24	24	68	68	3	1	2	81	81	3	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
67	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	members	miembros	69	69	3	1	7	82	82	3	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
68	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	and	y	70	70	3	1	3	83	83	3	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
69	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	13	13	71	71	3	1	2	85	85	3	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
70	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	associated	asociados	72	72	3	1	10	87	87	3	1	10	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
71	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	members	miembros	73	73	3	1	7	86	86	3	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
72	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	and	,_junto_con	74	74	3	1	3	88	88+89+90	3	3	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	4	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
73	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	experts	expertos	75	75	3	1	7	91	91	3	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
74	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	from	de	76	76	3	1	4	92	92	3	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
75	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	the	la	77	77	3	1	3	93	93	3	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
76	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	World	Mundial	78	78	3	1	5	95	95	3	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
77	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	Health	de_la_Salud	79	79	3	1	6	96	96+97+98	3	3	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
78	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	Organization	Organización	80	80	3	1	12	94	94	3	1	12	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-4	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
79	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	and	y	81	81	3	1	3	99	99	3	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	5	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
80	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	the	la	82	82	3	1	3	100	100	3	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
81	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	European	Europea_,	83	83	3	1	8	102	102+103	3	2	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
82	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	Commission	Comisión	84	84	3	1	10	101	101	3	1	10	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
83	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	discussed	debatieron	86	86	3	1	9	104	104	3	1	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
84	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	the	el	87	87	3	1	3	105	105	3	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
85	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	path	camino	88	88	3	1	4	106	106	3	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
86	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	towards	hacia	89	89	3	1	7	107	107	3	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
87	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	regulatory	regulatoria	90	90	3	1	10	110	110	3	1	10	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
88	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	alignment	la_alineación	91	91	3	1	9	108	108+109	3	2	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
89	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	on	en	92	92	3	1	2	111	111	3	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
90	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	the	la	93	93	3	1	3	112	112	3	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
91	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	global	mundial	94	94	3	1	6	114	114	3	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
92	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	response	respuesta	95	95	3	1	8	113	113	3	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
93	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	to	a	96	96	3	1	2	115	115	3	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
94	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	the	la	97	97	3	1	3	116	116	3	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
95	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	Omicron	Omicron	98	98	3	1	7	118	118	3	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
96	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	variant	variante	99	99	3	1	7	117	117	3	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
97	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	.	.	100	100	3	1	1	119	119	3	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
98	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	Meeting	---	85	217	3	1	7	0	0	0	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	117	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
99	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	The	La	101	101	4	1	3	120	120	4	1	3	6	0	2	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	0	-116	15789	680	1509680	[La[_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	653	1509434	1	0	0	_	[La[_
100	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	pandemic	pandemia	102	102	4	1	8	121	121	4	1	8	18	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	246	1944	1511624	pandemia_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	246	1509680	9	0	1716	pandemia_	pandemia_
101	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	has	ha	103	103	4	1	3	122	122	4	1	3	6	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	228	660	1512284	ha_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	228	1511624	3	0	296	ha_	ha_
102	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	increased	aumentado	104	104	4	1	9	123	123	4	1	9	20	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	364	31747	1544031	aumentado_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	364	1512284	10	0	1681	aumentado_	aumentado_
103	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	the_us	nuestra	105	105+108	4	2	5	124	124	4	1	6	22	2	3	1.1905	0	0	0	0	0	0	0	0	0	0	0	0	1	4	46119	99334	1890949	la_u[la_]nestra_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	150	1792997	6	1	1018	estra_[	la_u[la_]nestra_
104	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	urgency	urgencia	106	106	4	1	7	125	125	4	1	7	18	0	2	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	-2	394	4695	1792997	rgencia_u	0	0	0	0	0	0	---	0	0	0	0	0	0	---	193	1792847	1	0	0	u	rgencia_u
105	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	for	a_la_hora	107	107	4	1	3	126	126+127+128	4	3	1	20	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	3477	1644	1551408	a_la_hora_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	3477	1549764	10	0	1496	a_la_hora_	a_la_hora_
106	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	to	de	109	109	4	1	2	129	129	4	1	2	6	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	148	10774	1562182	de_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	148	1551408	3	0	8198	de_	de_
107	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	converge_on	encontrar	110	110+111	4	2	10	130	130	4	1	11	20	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	2576	2155	1564337	encontrar_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	2576	1562182	10	0	1878	encontrar_	encontrar_
108	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	responses	respuestas	112	112	4	1	9	131	131	4	1	9	22	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	277	4753	1569090	respuestas_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	277	1564337	11	0	1836	respuestas_	respuestas_
109	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	to	a_a	114	114	4	1	2	132	132+138	4	2	1	8	0	2	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	7	2	4240	6755	1599185	a_a_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	1323	1597824	2	0	588	a_	a_a_
110	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	existing	existentes	115	115	4	1	8	136	136	4	1	8	22	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-2	1	250	2845	1596208	[existentes_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	250	1593363	11	0	1571	existentes_	[existentes_
111	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	regulatory	regulatorios	116	116	4	1	10	135	135	4	1	10	26	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	181	1764	1589787	regulatorios_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	181	1588023	13	0	1512	regulatorios_	regulatorios_
112	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	challenges	los_retos	117	117	4	1	10	133	133+134	4	2	9	20	0	2	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-2	1	4309	3212	1588023	los_[retos_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	268	1587136	6	0	706	retos_	los_[retos_
113	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	and	y	118	118	4	1	3	137	137	4	1	3	4	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	4	1	1274	1616	1597824	y_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	1274	1596208	2	0	293	y_	y_
114	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	complex	complejos	119	119	4	1	7	141	141	4	1	7	20	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	4	1	363	3118	1627130	complejos_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	363	1624012	10	0	2034	complejos_	complejos_
115	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	new	futuros	120	120	4	1	3	142	142	4	1	3	14	0	2	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	2363	1686	1637359	f[uturos	0	0	0	0	0	0	---	0	0	0	0	0	0	---	1279	1635822	6	0	759	uturos	f[uturos
116	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	ones	los_retos	121	121	4	1	4	139	139+140	4	2	3	20	0	2	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-3	1	1810	22369	1624012	los_re[tos_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	1037	1623080	4	0	569	tos_	los_re[tos_
117	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	,	,	122	122	4	1	1	143	143	4	1	1	60	62	6	-123.0000	0	0	0	0	0	0	0	0	0	0	0	0	4	1	3304	73349	1682054	_pa[ap_desafios_[_soifasedactuales[selautcas[suturos.[.sorutu._[_The_pandemic_has_increased_the_urgency_for_us_to_converge_on_responses_both_to_existing_regulatory_challenges_and_complex_new_ones.	0	0	0	0	0	0	---	0	0	0	0	0	0	---	778	1637359	2	31	35481	._[_The_pandemic_has_increased_the_urgency_for_us_to_converge_on_responses_both_to_existing_regulatory_challenges_and_complex_new_ones.	_pa[ap_desafios_[_soifasedactuales[selautcas[suturos.[.sorutu._[_The_pandemic_has_increased_the_urgency_for_us_to_converge_on_responses_both_to_existing_regulatory_challenges_and_complex_new_ones.
118	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	said	afirmó	123	123	4	1	4	144	144	4	1	4	14	2	1	1.3077	0	0	0	0	0	0	0	0	0	0	0	0	1	1	515	5951	1692629	[afirmó_[_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	515	1686678	7	1	5031	afirmó_[_]	[afirmó_[_
119	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	Emer	Emer	124	124	4	1	4	145	145	4	1	4	14	16	1	-31.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	9214	4624	1686678	said_]manifes[sefinam	0	0	0	0	0	0	---	0	0	0	0	0	0	---	9214	1682054	7	8	4109	said_]manifes[sefinam]	said_]manifes[sefinam
120	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	Cooke	Cooke	125	125	4	1	5	146	146	4	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
121	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	,	,	126	126	4	1	1	147	147	4	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
122	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	Chair	la_presidenta	127	127	4	1	5	148	148+149	4	2	4	28	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	2575	2496	1750151	[la_presidenta_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	2575	1747655	14	0	1599	la_presidenta_	[la_presidenta_
123	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	of	de	128	128	4	1	2	150	150	4	1	2	6	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	897	375	1750526	de_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	897	1750151	3	0	217	de_	de_
124	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	ICMRA	la_ICMRA	129	129	4	1	5	151	151+152	4	2	4	18	0	2	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	460	12522	1765267	la_I[CMRA_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	302	1755808	5	0	2500	CMRA_[	la_I[CMRA_
125	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	and	y	130	130	4	1	3	153	153	4	1	3	4	0	2	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1426	383	1771284	[y[_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	654	1771065	1	0	0	_	[y[_
126	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	EMA	la_EMA	131	131	4	1	3	157	157+158	4	2	2	12	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	5	1	149	1891	1776750	la_EMA	0	0	0	0	0	0	---	0	0	0	0	0	0	---	149	1774859	6	0	743	la_EMA	la_EMA
127	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	’s	de	132	132	4	1	2	156	156	4	1	2	6	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-2	1	109	587	1774859	de_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	109	1774272	3	0	438	de_	de_
128	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	Executive	ejecutiva	133	133	4	1	9	155	155	4	1	9	20	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	118	1728	1774272	ejecutiva_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	118	1772544	10	0	1619	ejecutiva_	ejecutiva_
129	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	Director	directora	134	134	4	1	8	154	154	4	1	8	20	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	219	1260	1772544	directora_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	219	1771284	10	0	1142	directora_	directora_
130	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	.	.	135	135	4	1	1	159	159	4	1	1	12	14	7	-27.0000	0	0	0	0	0	0	0	0	0	0	0	0	5	1	322241	39076	1792653	En_esta,_los_participantes_de_los_24_miembros_y_los_13_miembros_asociados,_junto_con_expertos_de_la_Organización_Mundial_de_la_Salud_y_la_Comisión_Europea,_debatieron_el_camino_hacia_la_alineación_regulatoria_en_la_respuesta_mundial_a_la_variante_Omicron.[En_esta,_los_participantes_de_los_24_miembros_y_los_13_miembros_asociados,_junto_con_expertos_de_la_Organización_Mundial_de_la_Salud_y_la_Comisión_Europea,_debatieron_el_camino_hacia_la_alineación_regulatoria_en_la_respuesta_mundial_a_la_variante_Omicron[Chair_]P[PM[M[of_ICMRA_and_EMA’s_Executive_Director.]Y[Y_[_.	20298	167219	1	0	0	167219	En_esta,_los_participantes_de_los_24_miembros_y_los_13_miembros_asociados,_junto_con_expertos_de_la_Organización_Mundial_de_la_Salud_y_la_Comisión_Europea,_debatieron_el_camino_hacia_la_alineación_regulatoria_en_la_respuesta_mundial_a_la_variante_Omicron.	0	0	0	0	0	0	---	1148	1776750	1	3	0	.[	En_esta,_los_participantes_de_los_24_miembros_y_los_13_miembros_asociados,_junto_con_expertos_de_la_Organización_Mundial_de_la_Salud_y_la_Comisión_Europea,_debatieron_el_camino_hacia_la_alineación_regulatoria_en_la_respuesta_mundial_a_la_variante_Omicron.[En_esta,_los_participantes_de_los_24_miembros_y_los_13_miembros_asociados,_junto_con_expertos_de_la_Organización_Mundial_de_la_Salud_y_la_Comisión_Europea,_debatieron_el_camino_hacia_la_alineación_regulatoria_en_la_respuesta_mundial_a_la_variante_Omicron[Chair_]P[PM[M[of_ICMRA_and_EMA’s_Executive_Director.]Y[Y_[_.
131	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	Meeting	---	113	217	4	1	7	0	0	0	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	82	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
132	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	ICMRA	La_ICMRA	136	136	5	1	5	160	160+161	5	2	4	2	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	-81	11624	8756	187599	"""La_ICMRA_ha_demostrado_su_valor_durante_la_respuesta_a_la_COVID-19,_tanto_como_plataforma_para_el_intercambio_de_información_y_mejores_prácticas_como_para_proporcionar_liderazgo_estratégico,_intercambio_activo_de_información,_soluciones_pragmáticas_y_convergencia_regulatoria""."	11624	178843	1	0	0	178843	"""La_ICMRA_ha_demostrado_su_valor_durante_la_respuesta_a_la_COVID-19,_tanto_como_plataforma_para_el_intercambio_de_información_y_mejores_prácticas_como_para_proporcionar_liderazgo_estratégico,_intercambio_activo_de_información,_soluciones_pragmáticas_y_convergencia_regulatoria""."	0	0	0	0	0	0	---	0	0	0	0	0	---	"""La_ICMRA_ha_demostrado_su_valor_durante_la_respuesta_a_la_COVID-19,_tanto_como_plataforma_para_el_intercambio_de_información_y_mejores_prácticas_como_para_proporcionar_liderazgo_estratégico,_intercambio_activo_de_información,_soluciones_pragmáticas_y_convergencia_regulatoria""."
133	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	has	ha	137	137	5	1	3	162	162	5	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
134	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	proven	demostrado	138	138	5	1	6	163	163	5	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
135	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	its	su	139	139	5	1	3	164	164	5	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
136	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	value	valor	140	140	5	1	5	165	165	5	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
137	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	during	durante	141	141	5	1	6	166	166	5	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
138	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	the	la	142	142	5	1	3	167	167	5	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
139	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	COVID_-_19	a_la_COVID_-_19	143	143+144+145	5	3	8	169	169+170+171+172+173	5	5	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	6	3	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
140	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	response	respuesta	146	146	5	1	8	168	168	5	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-5	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
141	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	,	,	147	147	5	1	1	174	174	5	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	6	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
142	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	both	tanto	148	148	5	1	4	175	175	5	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
143	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	as	como	149	149	5	1	2	176	176	5	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
144	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	a_platform	plataforma	150	150+151	5	2	9	177	177	5	1	10	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
145	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	for	para	152	152	5	1	3	178	178	5	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
146	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	sharing	el_intercambio	153	153	5	1	7	179	179+180	5	2	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
147	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	information	de_información	154	154	5	1	11	181	181+182	5	2	10	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
148	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	and	y	155	155	5	1	3	183	183	5	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
149	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	best	buenas	156	156	5	1	4	184	184	5	1	4	12	2	1	1.3636	0	0	0	0	0	0	0	0	0	0	0	0	1	1	96934	103452	1994401	[mejores]buenas	0	0	0	0	0	0	---	0	0	0	0	0	0	---	96934	1890949	6	1	710	mejores]buenas	[mejores]buenas
150	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	practices	prácticas	157	157	5	1	9	185	185	5	1	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
151	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	and	como	158	158	5	1	3	186	186	5	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
152	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	for	para	162	162	5	1	3	187	187	5	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	4	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
153	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	providing	proporcionar	163	163	5	1	9	188	188	5	1	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
154	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	strategic	estratégico	164	164	5	1	9	190	190	5	1	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
155	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	leadership	liderazgo	165	165	5	1	10	189	189	5	1	10	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
156	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	,	,	166	166	5	1	1	191	191	5	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
157	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	active	activo	167	167	5	1	6	193	193	5	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
158	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	information	de_información	168	168	5	1	11	194	194+195	5	2	10	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
159	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	sharing	intercambio	169	169	5	1	7	192	192	5	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
160	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	,	,	170	170	5	1	1	196	196	5	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	4	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
161	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	pragmatic	pragmáticas	171	171	5	1	9	198	198	5	1	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
162	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	solutions	soluciones	172	172	5	1	9	197	197	5	1	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
163	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	and	y	173	173	5	1	3	199	199	5	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
164	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	regulatory	regulatoria	174	174	5	1	10	201	201	5	1	10	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
165	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	convergence	convergencia	175	175	5	1	11	200	200	5	1	11	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
166	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	.	.	176	176	5	1	1	202	202	5	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
167	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	Meeting	---	159	217	5	1	7	0	0	0	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	41	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
168	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	Meeting	---	160	217	5	1	7	0	0	0	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
169	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	Meeting	---	161	217	5	1	7	0	0	0	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
170	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	One	Uno	177	177	6	1	3	203	203	6	1	3	2	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-2	-40	8756	7410	195009	Uno_de_los_objetivos_de_la_reunión_era_intercambiar_información_sobre_los_enfoques_regulatorios_de_la_respuesta_a_la_COVID-19,__reflexionar_sobre_qué_se_ha_aprendido_en_este_tiempo_e_identificar_prioridades_y_oportunidades_para_reforzar_la_regulación_ante_futuras_emergencias_de_salud_pública.	8756	187599	1	0	0	187599	Uno_de_los_objetivos_de_la_reunión_era_intercambiar_información_sobre_los_enfoques_regulatorios_de_la_respuesta_a_la_COVID-19,__reflexionar_sobre_qué_se_ha_aprendido_en_este_tiempo_e_identificar_prioridades_y_oportunidades_para_reforzar_la_regulación_ante_futuras_emergencias_de_salud_pública.	0	0	0	0	0	0	---	0	0	0	0	0	---	Uno_de_los_objetivos_de_la_reunión_era_intercambiar_información_sobre_los_enfoques_regulatorios_de_la_respuesta_a_la_COVID-19,__reflexionar_sobre_qué_se_ha_aprendido_en_este_tiempo_e_identificar_prioridades_y_oportunidades_para_reforzar_la_regulación_ante_futuras_emergencias_de_salud_pública.
171	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	of	de	178	178	6	1	2	204	204	6	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
172	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	the	los	179	179	6	1	3	205	205	6	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
173	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	goals	objetivos	180	180	6	1	5	206	206	6	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
174	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	of	de	181	181	6	1	2	207	207	6	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
175	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	the	la	182	182	6	1	3	208	208	6	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
176	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	meeting	reunión	183	183	6	1	7	209	209	6	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
177	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	was	era	184	184	6	1	3	210	210	6	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
178	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	to_exchange	intercambiar	185	185+186	6	2	10	211	211	6	1	11	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
179	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	information	información	187	187	6	1	11	212	212	6	1	11	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
180	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	on	sobre	188	188	6	1	2	213	213	6	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
181	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	regulatory	regulatorios	189	189	6	1	10	216	216	6	1	10	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
182	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	approaches	los_enfoques	190	190	6	1	10	214	214+215	6	2	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
183	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	to	de	191	191	6	1	2	217	217	6	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
184	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	the	la	192	192	6	1	3	218	218	6	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
185	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	COVID_-_19	a_la_COVID_-_19	193	193+194+195	6	3	8	220	220+221+222+223+224	6	5	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	6	3	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
186	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	response	respuesta	196	196	6	1	8	219	219	6	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-5	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
187	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	,	,	197	197	6	1	1	225	225	6	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	6	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
188	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	draw	reflexionar	198	198	6	1	4	226	226	6	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
189	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	lessons	sobre_qué	199	199	6	1	7	227	227+228	6	2	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
190	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	learned	se_ha_aprendido_en_este_tiempo	200	200	6	1	7	229	229+230+231+232+233+234	6	6	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	6	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
191	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	and	e	201	201	6	1	3	235	235	6	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
192	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	identify	identificar	202	202	6	1	8	236	236	6	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
193	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	priorities	prioridades	204	204	6	1	10	237	237	6	1	10	16	4	1	1.6154	0	0	0	0	0	0	0	0	0	0	0	0	1	2	102742	249214	2243615	futuras_[futuras_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	102742	1994401	8	2	65747	futuras_[futuras_]	futuras_[futuras_
194	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	and	y	205	205	6	1	3	238	238	6	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
195	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	opportunities	oportunidades	206	206	6	1	13	239	239	6	1	13	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
196	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	to	para	207	207	6	1	2	240	240	6	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
197	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	strengthen	reforzar	208	208	6	1	10	241	241	6	1	10	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
198	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	regulatory_preparedness	la_regulación	209	209+210	6	2	22	242	242+243	6	2	22	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
199	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	for	ante	211	211	6	1	3	244	244	6	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
200	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	future	futuras	212	212	6	1	6	245	245	6	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
201	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	public	pública	213	213	6	1	6	249	249	6	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	4	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
202	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	health	de_salud	214	214	6	1	6	247	247+248	6	2	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
203	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	emergencies	emergencias	215	215	6	1	11	246	246	6	1	11	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
204	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	.	.	216	216	6	1	1	250	250	6	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	4	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
205	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	Meeting	---	203	217	6	1	7	0	0	0	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
206	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	participants	Los_participantes	218	218	7	1	12	251	251+252	7	2	11	2	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	7410	13102	208111	Los_participantes_también_reflexionaron_sobre_otros_temas_importantes_que_están_en_la_agenda_de_las_agencias_reguladoras_de_medicamentos_y_los_organismos_de_salud_pública,_como_por_ejemplo_la_lucha_contra_la_resistencia_a_los_antimicrobianos,_los_medicamentos_para_uso_en_el_embarazo_y_la_integridad_de_la_cadena_de_suministro.	7410	195009	1	0	0	195009	Los_participantes_también_reflexionaron_sobre_otros_temas_importantes_que_están_en_la_agenda_de_las_agencias_reguladoras_de_medicamentos_y_los_organismos_de_salud_pública,_como_por_ejemplo_la_lucha_contra_la_resistencia_a_los_antimicrobianos,_los_medicamentos_para_uso_en_el_embarazo_y_la_integridad_de_la_cadena_de_suministro.	0	0	0	0	0	0	---	0	0	0	0	0	---	Los_participantes_también_reflexionaron_sobre_otros_temas_importantes_que_están_en_la_agenda_de_las_agencias_reguladoras_de_medicamentos_y_los_organismos_de_salud_pública,_como_por_ejemplo_la_lucha_contra_la_resistencia_a_los_antimicrobianos,_los_medicamentos_para_uso_en_el_embarazo_y_la_integridad_de_la_cadena_de_suministro.
207	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	also	también	219	219	7	1	4	253	253	7	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
208	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	reflected	reflexionaron	220	220	7	1	9	254	254	7	1	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
209	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	on	sobre	221	221	7	1	2	255	255	7	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
210	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	other	otros	222	222	7	1	5	256	256	7	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
211	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	important	importantes	223	223	7	1	9	258	258	7	1	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
212	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	issues	temas	224	224	7	1	6	257	257	7	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
213	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	that	que	225	225	7	1	4	259	259	7	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
214	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	are	están	226	226	7	1	3	260	260	7	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
215	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	on	en	227	227	7	1	2	261	261	7	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
216	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	the	la	228	228	7	1	3	262	262	7	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
217	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	agenda	agenda	229	229	7	1	6	263	263	7	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
218	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	of	de_las	230	230	7	1	2	264	264+265	7	2	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
219	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	medicines	de_medicamentos	231	231	7	1	9	268	268+269	7	2	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	4	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
220	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	regulators	agencias_reguladoras	232	232	7	1	10	266	266+267	7	2	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
221	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	and	y	233	233	7	1	3	270	270	7	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	4	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
222	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	public	pública	234	234	7	1	6	275	275	7	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	5	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
223	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	health	de_salud	235	235	7	1	6	273	273+274	7	2	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
224	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	bodies	los_organismos	236	236	7	1	6	271	271+272	7	2	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
225	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	,	,	237	237	7	1	1	276	276	7	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	5	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
226	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	including	como_por_ejemplo	238	238	7	1	9	277	277+278+279	7	3	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
227	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	the	la	239	239	7	1	3	280	280	7	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
228	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	fight	lucha	240	240	7	1	5	281	281	7	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
229	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	against	contra	241	241	7	1	7	282	282	7	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
230	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	antimicrobial	a_los_antimicrobianos	242	242	7	1	13	285	285+286+287	7	3	11	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	5	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
231	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	resistance	la_resistencia	243	243	7	1	10	283	283+284	7	2	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-4	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
232	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	,	,	244	244	7	1	1	288	288	7	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	5	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
233	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	medicines	los_medicamentos	245	245	7	1	9	289	289+290	7	2	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
234	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	for	para	246	246	7	1	3	291	291	7	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
235	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	use	uso	247	247	7	1	3	292	292	7	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
236	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	in	en	248	248	7	1	2	293	293	7	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
237	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	pregnancy	el_embarazo	249	249	7	1	9	294	294+295	7	2	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
238	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	and	y	250	250	7	1	3	296	296	7	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
239	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	supply	de_suministro	251	251	7	1	6	302	302+303	7	2	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	7	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
240	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	chain	de_la_cadena	252	252	7	1	5	299	299+300+301	7	3	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-4	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
241	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	integrity	la_integridad	253	253	7	1	9	297	297+298	7	2	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
242	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	.	.	254	254	7	1	1	304	304	7	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	7	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
243	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	The	La	255	255	8	1	3	305	305	8	1	3	2	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	13102	9055	217166	La_reunión_fue_organizada_por_la_Agencia_Nacional_de_Vigilancia_Sanitaria_de_Brasil_(ANVISA)_y_copresidida_por_Antonio_Barra_Torres,_Director_de_ANVISA,_y_Emer_Cooke,_Presidenta_de_ICMRA_y_Directora_Ejecutiva_de_la_EMA.	13102	208111	1	0	0	208111	La_reunión_fue_organizada_por_la_Agencia_Nacional_de_Vigilancia_Sanitaria_de_Brasil_(ANVISA)_y_copresidida_por_Antonio_Barra_Torres,_Director_de_ANVISA,_y_Emer_Cooke,_Presidenta_de_ICMRA_y_Directora_Ejecutiva_de_la_EMA.	0	0	0	0	0	0	---	0	0	0	0	0	---	La_reunión_fue_organizada_por_la_Agencia_Nacional_de_Vigilancia_Sanitaria_de_Brasil_(ANVISA)_y_copresidida_por_Antonio_Barra_Torres,_Director_de_ANVISA,_y_Emer_Cooke,_Presidenta_de_ICMRA_y_Directora_Ejecutiva_de_la_EMA.
244	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	meeting	reunión	256	256	8	1	7	306	306	8	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
245	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	was	fue	257	257	8	1	3	307	307	8	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
246	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	hosted	organizada	258	258	8	1	6	308	308	8	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
247	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	by	por	259	259	8	1	2	309	309	8	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
248	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	the	la	260	260	8	1	3	310	310	8	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
249	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	Brazilian	de_Brasil	261	261	8	1	9	316	316+317	8	2	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	7	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
250	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	National	Nacional	262	262	8	1	8	312	312	8	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-5	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
251	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	Health	Sanitaria	263	263	8	1	6	315	315	8	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
252	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	Surveillance	de_Vigilancia	264	264	8	1	12	313	313+314	8	2	11	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
253	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	Agency	Agencia	265	265	8	1	6	311	311	8	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
254	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	(	(	266	266	8	1	1	318	318	8	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	7	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
255	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	ANVISA	ANVISA	267	267	8	1	6	319	319	8	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
256	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	)	)	268	268	8	1	1	320	320	8	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
257	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	and	y	269	269	8	1	3	321	321	8	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
258	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	co_-_chaired	copresidida	270	270+271+272	8	3	10	322	322	8	1	12	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	3	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
259	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	by	por	273	273	8	1	2	323	323	8	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
260	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	Antonio	Antonio	274	274	8	1	7	324	324	8	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
261	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	Barra	Barra	275	275	8	1	5	325	325	8	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
262	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	Torres	Torres	276	276	8	1	6	326	326	8	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
263	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	,	,	277	277	8	1	1	327	327	8	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
264	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	Director	Director	278	278	8	1	8	328	328	8	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
265	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	of	de	279	279	8	1	2	329	329	8	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
266	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	ANVISA	ANVISA	280	280	8	1	6	330	330	8	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
267	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	,	,	281	281	8	1	1	331	331	8	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
268	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	and	y	282	282	8	1	3	332	332	8	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
269	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	Emer	Emer	283	283	8	1	4	333	333	8	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
270	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	Cooke	Cooke	284	284	8	1	5	334	334	8	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
271	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	,	,	285	285	8	1	1	335	335	8	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
272	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	Chair	Presidenta	286	286	8	1	5	336	336	8	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
273	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	of	de	287	287	8	1	2	337	337	8	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
274	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	ICMRA	la_ICMRA	288	288	8	1	5	338	338+339	8	2	4	6	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	183467	574	2244189	[_la	0	0	0	0	0	0	---	0	0	0	0	0	0	---	183467	2243615	3	0	574	_la	[_la
275	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	and	y	289	289	8	1	3	340	340	8	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
276	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	EMA	la_EMA	290	290	8	1	3	344	344+345	8	2	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	5	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
277	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	’s	de	291	291	8	1	2	343	343	8	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
278	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	Executive	Ejecutiva	292	292	8	1	9	342	342	8	1	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
279	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	Director	Directora	293	293	8	1	8	341	341	8	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
280	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	.	.	294	294	8	1	1	346	346	8	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	5	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
281	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	A	un	295	295	9	1	1	358	358	9	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	12	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
282	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	meeting	de_la_reunión	296	296	9	1	7	360	360+361+362	9	3	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	4	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
283	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	report	informe	297	297	9	1	6	359	359	9	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
284	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	summarising	con	298	298	9	1	11	363	363	9	1	11	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	4	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
285	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	the	los	299	299	9	1	3	364	364	9	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
286	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	outcomes	resultados	300	300	9	1	8	365	365	9	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
287	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	of	de	301	301	9	1	2	366	366	9	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
288	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	the	los	302	302	9	1	3	367	367	9	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
289	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	discussions	debates	303	303	9	1	11	368	368	9	1	11	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
290	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	will_be	se	304	304+305	9	2	6	349	349	9	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-19	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
291	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	published	publicará	306	306	9	1	9	350	350	9	1	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
292	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	on	en	307	307	9	1	2	351	351	9	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
293	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	the	la	308	308	9	1	3	352	352	9	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
294	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	ICMRA	de_la_IMCRA	309	309	9	1	5	355	355+356+357	9	3	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	5	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
295	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	website	página_web	310	310	9	1	7	353	353+354	9	2	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-4	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
296	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	in_due	Más	311	311+312	9	2	5	347	347	9	1	6	2	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-6	2	9055	817162	1034328	Más_adelante_se_publicará_en_la_página_web_de_la_IMCRA_un_informe_de_la_reunión_con_los_resultados_de_los_debates.	9055	217166	1	0	0	217166	Más_adelante_se_publicará_en_la_página_web_de_la_IMCRA_un_informe_de_la_reunión_con_los_resultados_de_los_debates.[	0	0	0	0	0	0	---	0	0	0	0	0	---	Más_adelante_se_publicará_en_la_página_web_de_la_IMCRA_un_informe_de_la_reunión_con_los_resultados_de_los_debates.
297	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	course	adelante	313	313	9	1	6	348	348	9	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
298	NEUROTRAD_3	P30_PP1	NEUROTRAD_3@P30_PP1	en	es	PP	1	P30	.	.	314	314	9	1	1	369	369	9	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	21	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---